Login

Willkomen zurück, bitte gebe deine Zugangsdaten ein!

Passwort vergessen

Anmeldung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin | The Manila Times

HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), today announced that an abstract featuring pooled cardiac safety data for its lead drug candidate Annamycin (also known as 'L-Annamycin” or 'naxtarubicin”), has been accepted for poster presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2026, in Chicago, Illinois. Access the abstract here.

Ähnliche Seiten

https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/beyondspring-announces-poster-presentation-at-2026-asco-annual-meeting/2346086

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/beyondspring-announces-poster-presentation-at-2026-asco-annual-meeting/2346086
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting/2349722

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting/2349722
https://www.manilatimes.net/2026/05/22/tmt-newswire/pr-newswire/formosa-pharmaceuticals-announces-presentation-of-tsy-310-at-the-2026-asco-annual-meeting/2349736

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/pr-newswire/formosa-pharmaceuticals-announces-presentation-of-tsy-310-at-the-2026-asco-annual-meeting/2349736
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine-pipeline/2349690

Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine-pipeline/2349690